Fujitsu Launches AI-powered Physical Rehabilitation Solution 'HOPE ROMREC' in Japan
Automated system input for visual measurement and measured values of shoulder and elbow joint range of motion
TOKYO, Feb 24, 2021 - (JCN Newswire) - Fujitsu today announced the launch of a new AI-powered physical rehabilitation solution in Japan, the "FUJITSU Healthcare Solution HOPE ROMREC", offering medical institutions like hospitals and clinics a powerful new tool for rehabilitation and orthopedic therapies. The solution leverages a new AI technology to automatically measure the range of motion(1) of the shoulder and elbow joints from videos of patients' rehabilitation sessions.
|Fig. 1 Automatic detection of joint range of motion|
|Fig. 2 HOPE ROMREC Screen Image|
"HOPE ROMREC" is a solution that automatically measures, records, and visualizes the angles of a patient's shoulder and elbow by estimating a three-dimensional skeleton from rehabilitation videos captured using a tablet device(2). The solution leverages an image analysis AI engine developed by Fujitsu consisting of multiple AI image recognition models.
The technology offers the potential to greatly improve the efficiency of the visual measurement of a patient's joint curvature using a goniometer(3), a task conventionally performed by physical therapists and occupational therapists. Ultimately, the solution will help medical professionals evaluate the effectiveness of physical and occupational therapies and determine the degree of their patients' conditions.
Going forward, Fujitsu plans to continue strengthening the HOPE ROMREC solution and increase the number of measurement sites for range of motion detection. Fujitsu additionally plans to incorporate functions including automatic measurement of range of motion by simply sending video taken by a patient at home to their hospital or clinic, contributing to the realization of remote rehabilitation.
In rehabilitation therapy, measuring range of motion is necessary to determine factors inhibiting joint movement, evaluate the effects of physical and occupational therapy, and determine the extent of a patient's condition. Physical therapists and occupational therapists make these measurements visually using goniometers, etc., however, which contributes to variation in measurement values from person to person. Conventional automatic measurement of range of motion demands special equipment, such as an acceleration sensor, which have not yet been widely implemented in the field. In addition to the system input work of measurement values, therapists now must also carry out extensive disinfection in rehabilitation areas to prevent COVID-19 infections , increasing the burden on medical facilities.
To address these challenges, Fujitsu has developed the HOPE ROMREC solution, which automatically measures the range of motion of the shoulder and elbow joints by analyzing videos of patients' rehabilitation with AI. Sales of the new solution will begin in Japan on February 24.
Key Features of the New Solution
1. Automatic measurement of patient's range of motion with image analysis AI engine
Using an image analysis AI engine, which combines multiple AI image recognition models with previously learned motion patterns of a person's shoulder and elbow joints, it's possible to replicate a three-dimensional skeleton from a patient's rehabilitation video and automatically measure angles in a total of 16 motion directions for the shoulder and elbow. Therapists take the rehabilitation videos with a tablet's camera and send them to a dedicated PC equipped with an image analysis AI engine.
The measured values are recorded as data and can be displayed as a time-series line graph, making it easy to grasp the effect and transition of individual patients' rehabilitation.
It eliminates the need for accelerometers and joint markers on patients, as well as multiple cameras and specialized equipment such as infrared laser radar, which are required for conventional automated measurements of range of motion.
This greatly increases the efficiency of therapists' work, which uses goniometers to visually measure a patient's range of motion, and helps assess the effectiveness of physical and occupational therapy and determine the degree of the patient's condition.
2. Voice input function of the measured value
In order to reduce the workload of therapists in rehabilitation areas other than shoulders and elbows, for which measurements can be automatically taken for the range of joint motion from video, the system is equipped with a voice input function that enables the tablet to automatically record and recognize when the user speaks the body part, direction of movement, and measurement values measured by their goniometer.
This eliminates the need for note-taking and system input of measurement values that therapists typically perform, and enables measurement results to be recorded efficiently and quickly.
3. Easily link data with electronic medical records systems
Since the measurement data can be exported as CSV data, it can be easily incorporated into an electronic medical record system and a medical certificate preparation system, and it can be utilized for higher quality rehabilitation treatment based on the patient's treatment results and treatment plans.
(1) range of joint movement:
The maximum range of physical movement of each joint of the body, measured in degrees
(2) tablet device:
Presently available on iPad
Measurement device used by physical therapists, occupational therapists, etc. to measure range of joint movement.
Fujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 130,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.9 trillion yen (US$35 billion) for the fiscal year ended March 31, 2020. For more information, please see www.fujitsu.com.
Source: Fujitsu Ltd
Sectors: Artificial Intel [AI], MedTech
Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Press Release
More Latest Release >>
DENSO Announces First Quarter Financial Results
Jul 30, 2021 17:12 JST
Showa Denko Group Challenges to Realize Carbon Neutrality by 2050
Jul 30, 2021 17:00 JST
Agreement Concluded for Mitsubishi Power to be Integrated into MHI
Jul 30, 2021 16:40 JST
DENSO Provides First Quarter Results and Progress Updates in Key Focus
Jul 30, 2021 15:48 JST
Port of Rotterdam Authority, Koole Terminals, Chiyoda Corporation and Mitsubishi Corporation Sign MoU to Study Commercial-Scale Hydrogen Imports to the Netherlands
Jul 30, 2021 12:30 JST
Mitsubishi Motors to Launch the All-New Outlander PHEV Model with a New-Generation PHEV System This Fiscal Year
Jul 30, 2021 10:46 JST
Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab (BAN2401)
Jul 30, 2021 10:07 JST
Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer's Disease at AAIC 2021
Jul 30, 2021 09:24 JST
"Tanegashima Loggerhead Sea Turtle Survey 2021" Takes Place amid Covid Restrictions
Jul 29, 2021 17:50 JST
Eisai Listed for 20th Consecutive Year in FTSE4Good Index Series, An Index for Socially Responsible Investment
Jul 29, 2021 17:34 JST
Mazda Production and Sales Results for June 2021 and for January through June 2021
Jul 29, 2021 17:16 JST
Honda Sets All-Time Accumulated Production Records for the First Half of Year in China
Jul 29, 2021 15:40 JST
Toyota Releases Sales, Production, and Export Results for the First Half of 2021
Jul 29, 2021 14:05 JST
Showa Denko Installs Additional Lines to Produce Aluminum Heat Radiators for xEVs
Jul 29, 2021 11:30 JST
Mitsubishi Corporation: Regeneration Project / Investment in Australian Integrated Carbon Pty Ltd
Jul 29, 2021 11:12 JST
Biogen and Eisai Announce ADUHELM (aducanumab-avwa) Data Presentations at Alzheimer's Association International Conference 2021
Jul 27, 2021 09:00 JST
Mitsubishi Shipbuilding Holds Launch Ceremony in Shimonoseki for First MRRV for the Philippines Department of Transportation
Jul 26, 2021 15:56 JST
Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma
Jul 23, 2021 09:17 JST
Suzuki and Daihatsu Join Commercial Japan Partnership for Dissemination of CASE Technologies in Mini-commercial Vehicles
Jul 21, 2021 17:09 JST
Eisai to Present Latest Data on Pipeline Assets in The Area of Alzheimer's Disease and Dementia at AAIC 2021
Jul 21, 2021 10:34 JST